Breaking News Instant updates and real-time market news.

ABEO

Abeona Therapeutics

$16.10

-1.45 (-8.26%)

, ONCE

Spark Therapeutics

$84.23

-1.97 (-2.29%)

07:12
10/16/17
10/16
07:12
10/16/17
07:12

Abeona Therapeutics price target raised to $30 from $20 at H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Abeona Therapeutics (ABEO) to $30 saying the company's R&D day showcased its pipeline value. Further, the FDA panel vote for Spark Therapeutics' (ONCE) Luxturna indicates a positive gene therapy outlook, the analyst tells investors in a research note. He reiterates a Buy rating on Abeona.

ABEO

Abeona Therapeutics

$16.10

-1.45 (-8.26%)

ONCE

Spark Therapeutics

$84.23

-1.97 (-2.29%)

  • 17

    Oct

  • 23

    Oct

  • 06

    Nov

  • 12

    Jan

ABEO Abeona Therapeutics
$16.10

-1.45 (-8.26%)

10/10/17
SBSH
10/10/17
INITIATION
Target $32
SBSH
Buy
Abeona Therapeutics initiated with a Buy at Citi
Citi analyst Liav Abraham started Abeona Therapeutics with a Buy rating and $32 price target. The analyst sees a regulatory pathway to approval for the company's two lead assets, ABO-102 for Sanfilippo Syndrome and EB-101 for rare genetic skin disease, and multiple catalysts over the next 12 months.
10/10/17
10/10/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Abeona Therapeutics (ABEO) initiated with a Buy at Citi. 2. AMC Networks (AMCX) initiated with an Outperform at Wells Fargo. 3. Dominion Midstream (DM) initiated with a Buy at Guggenheim. 4. Tremont Mortgage Trust (TRMT) initiated with a Buy at UBS. 5. PPL Corp. (PPL) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage,
10/11/17
CANT
10/11/17
NO CHANGE
Target $34
CANT
Abeona Therapeutics price target raised to $34 from $21 at Cantor Fitzgerald
10/11/17
CANT
10/11/17
NO CHANGE
Target $34
CANT
Overweight
Abeona Therapeutics price target to $34 on MPS IIIA data at Cantor Fitzgerald
As previously reported, Cantor Fitzgerald raised Abeona Therapeutics' price target to $34 from $21 following new initial MPS IIIA data from a third patient cohort dosing at a higher and potentially pivotal stage dose of ABO-102. In addition the company expects to initiate a Phase III study in 1H 2018 for its EB-101 program. The analyst increased his probability of success to 60% from 30% for both the MPS IIIA and EB programs and reiterates an Overweight rating on shares.
ONCE Spark Therapeutics
$84.23

-1.97 (-2.29%)

10/13/17
JEFF
10/13/17
NO CHANGE
Target $95
JEFF
Buy
Spark shares will continue to rise into 2018, says Jefferies
After hosting a "fireside chat" with the company and an FDA panel's unanimous vote in favor of Luxturna approval, Jefferies analyst Michael Yee says he believes shares of Spark Therapeutics will continue to go up into 2018. The analyst expects a "fairly modest but steady" uptake of Luxturna upon approval given a rare disease and limited centers to start. He believes his 2018 U.S. sales range of $40M-$50M is "theoretically doable." Yee keeps a Buy rating on Spark with a $95 price target.
10/13/17
BMOC
10/13/17
NO CHANGE
BMOC
Spark Therapeutics price target raised to $101 from $89 at BMO Capital
BMO Capital analyst Matthew Luchini raised his price target on Spark after an FDA panel unanimously recommended approval of its LUXTURNA, a gene therapy for the treatment of patients with vision loss due to retinal disease. The analyst now "assigns full credit" to the drug in his estimates, but he adds that the company's hemophilia A drugs are the "primary" catalyst for the stock over the near-term. The analyst keeps an Outperform rating on the shares.
10/13/17
STFL
10/13/17
NO CHANGE
Target $101
STFL
Buy
Spark Therapeutics price target raised to $101 from $92 at Stifel
Stifel analyst Stephen Willey said the vote of an FDA advisory committee in favor of the overall benefit-risk profile of Spark Therapeutics' voretigene neparvovec was "precisely in-line" with both his and the consensus expectation and he now expects the pricing/reimbursement debate to accelerate ahead of the January PDUFA date for the treatment. The analyst, who has adjusted both his expectations for pricing and some patient-related factors, raised his price target on Spark shares to $101 from $92 and keeps a Buy rating on the stock.
10/13/17
CANT
10/13/17
NO CHANGE
Target $105
CANT
Overweight
Spark Therapeutics price target raised to $105 from $94 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Spark Therapeutics to $105 following the unanimous advisory committee recommendation to approve Luxturna for the treatment of biallelic RPE65 mutation-associated retinal dystrophy. The analyst expects expedited approval for Luxturna well before its January 12, 2018, FDA action date. He keeps an Overweight rating on Spark Therapeutics.

TODAY'S FREE FLY STORIES

HPQ

HP Inc.

$22.46

0.34 (1.54%)

17:53
11/21/17
11/21
17:53
11/21/17
17:53
Hot Stocks
Breaking Hot Stocks news story on HP Inc. »

HP Inc. says returned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TMQ

Trilogy Metals

$0.92

-0.0211 (-2.25%)

17:53
11/21/17
11/21
17:53
11/21/17
17:53
Syndicate
Breaking Syndicate news story on Trilogy Metals »

Trilogy Metals files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNO

Terreno Realty

$37.74

0.74 (2.00%)

17:50
11/21/17
11/21
17:50
11/21/17
17:50
Initiation
Terreno Realty initiated  »

Terreno Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HPQ

HP Inc.

$22.47

0.355 (1.61%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Hot Stocks
HP Inc.: 'Stay tuned' for news on metal 3D printing »

Says plans to introduce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

THC

Tenet

$13.34

0.17 (1.29%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Initiation
Tenet initiated  »

Tenet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPNT

LifePoint

$43.85

0.65 (1.50%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Initiation
LifePoint initiated  »

LifePoint initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHCG

LHC Group

$67.98

1.46 (2.19%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
LHC Group initiated  »

LHC Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

HLS

HealthSouth

$48.46

0.85 (1.79%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
HealthSouth initiated  »

HealthSouth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$75.89

1.28 (1.72%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
HCA Healthcare initiated  »

HCA Healthcare initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AMED

Amedisys

$54.97

2.29 (4.35%)

17:45
11/21/17
11/21
17:45
11/21/17
17:45
Initiation
Amedisys initiated  »

Amedisys initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.46

0.34 (1.54%)

17:45
11/21/17
11/21
17:45
11/21/17
17:45
Hot Stocks
HP Inc. sees printing segment continuing to make 'significant' progress »

Comments taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

17:45
11/21/17
11/21
17:45
11/21/17
17:45
General news
Breaking General news story  »

Federal Reserve Chair…

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

, AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

17:38
11/21/17
11/21
17:38
11/21/17
17:38
Periodicals
Nippon made all-cash offer to buy Axalta Coating, Reuters reports »

Japan's Nippon Paint…

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIVO

TiVo

$17.65

0.15 (0.86%)

, CMCSA

Comcast

$36.42

0.59 (1.65%)

17:34
11/21/17
11/21
17:34
11/21/17
17:34
Hot Stocks
TiVo wins ITC patent lawsuit against Comcast »

TiVo (TIVO) has won its…

TIVO

TiVo

$17.65

0.15 (0.86%)

CMCSA

Comcast

$36.42

0.59 (1.65%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.73

0.29 (1.76%)

, AXTA

Axalta Coating

$33.87

0.33 (0.98%)

17:27
11/21/17
11/21
17:27
11/21/17
17:27
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

GME

GameStop

$16.73

0.29 (1.76%)

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

EXEL

Exelixis

$26.05

0.4 (1.56%)

GES

Guess

$17.95

0.17 (0.96%)

CAL

Caleres

$30.99

0.05 (0.16%)

HPQ

HP Inc.

$22.46

0.34 (1.54%)

CRM

Salesforce

$108.80

1.43 (1.33%)

HPE

HP Enterprise

$14.12

0.03 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 27

    Nov

  • 28

    Nov

  • 11

    Dec

SSY

SunLink Health Systems

$1.52

0.03 (2.01%)

17:27
11/21/17
11/21
17:27
11/21/17
17:27
Hot Stocks
SunLink Health Systems commences tender offer to repurchase 1.56M shares »

SunLink Health Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYHT

Shineco

$3.26

-0.27 (-7.65%)

17:26
11/21/17
11/21
17:26
11/21/17
17:26
Syndicate
Breaking Syndicate news story on Shineco »

Shineco files $25M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMNI

Rimini Street

$7.54

0.0842 (1.13%)

17:22
11/21/17
11/21
17:22
11/21/17
17:22
Syndicate
Rimini Street files to sell 22.11M shares of common stock for holders »

Also files to sell 6.06M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$108.80

1.43 (1.33%)

17:20
11/21/17
11/21
17:20
11/21/17
17:20
Earnings
Breaking Earnings news story on Salesforce »

Salesforce says sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

GME

GameStop

$16.74

0.31 (1.89%)

17:18
11/21/17
11/21
17:18
11/21/17
17:18
Hot Stocks
GameStop 'on track' to achieve FY17 collectibles revenue view »

Says "on track"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

GME

GameStop

$16.73

0.29 (1.76%)

, NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

17:16
11/21/17
11/21
17:16
11/21/17
17:16
Hot Stocks
GameStop: Xbox One X has already had 'strong start' »

GameStop (GME) says it…

GME

GameStop

$16.73

0.29 (1.76%)

NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

MSFT

Microsoft

$83.72

1.19 (1.44%)

ATVI

Activision Blizzard

$64.50

0.57 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$108.80

1.43 (1.33%)

, AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

17:14
11/21/17
11/21
17:14
11/21/17
17:14
Hot Stocks
Salesforce: Amazon.com continues to be key partner in International expansion »

Says International…

CRM

Salesforce

$108.80

1.43 (1.33%)

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

  • 18

    Mar

ALGT

Allegiant Travel

$138.40

0.85 (0.62%)

17:14
11/21/17
11/21
17:14
11/21/17
17:14
Hot Stocks
Allegiant Travel reaches tentative agreement with TWU »

Allegiant announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.73

0.29 (1.76%)

, NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

17:12
11/21/17
11/21
17:12
11/21/17
17:12
Hot Stocks
GameStop: Q4 hardware sales to be driven by Switch, Xbox One X »

GameStop (GME) says Q4…

GME

GameStop

$16.73

0.29 (1.76%)

NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

MSFT

Microsoft

$83.72

1.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

JE

Just Energy

$4.43

-0.05 (-1.12%)

17:10
11/21/17
11/21
17:10
11/21/17
17:10
Hot Stocks
Just Energy launches operations in Japan »

Just Energy Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.